Taro Pharmaceutical Industries Ltd
NYSE:TARO
Taro Pharmaceutical Industries Ltd
Depreciation & Amortization
Taro Pharmaceutical Industries Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Depreciation & Amortization
$33.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Depreciation & Amortization
$1.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-4%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Depreciation & Amortization
₪13.2m
|
CAGR 3-Years
59%
|
CAGR 5-Years
321%
|
CAGR 10-Years
56%
|
Mediwound Ltd
NASDAQ:MDWD
|
Depreciation & Amortization
$1.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
18%
|
CAGR 10-Years
14%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Depreciation & Amortization
₪29.9m
|
CAGR 3-Years
15%
|
CAGR 5-Years
23%
|
CAGR 10-Years
16%
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Depreciation & Amortization
₪3.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Taro Pharmaceutical Industries Ltd's Depreciation & Amortization?
Depreciation & Amortization
33.7m
USD
Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Depreciation & Amortization amounts to 33.7m USD.
What is Taro Pharmaceutical Industries Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
7%
Over the last year, the Depreciation & Amortization growth was 20%. The average annual Depreciation & Amortization growth rates for Taro Pharmaceutical Industries Ltd have been 14% over the past three years , 13% over the past five years , and 7% over the past ten years .